Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects

Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by injection) fluoroquinolone drugs. The FDA review showed that there were persistent (lasting 30 days or longer after stopping use of fluoroquinolones) and disabling side effects linked to the use of fluoroquinolone products.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-09

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data